Your browser doesn't support javascript.
loading
Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
Wang, Yaqiong; Yan, Xiaoxiang; Mi, Shouling; Li, Zhang; Wang, Yuexiang; Zhu, Hong; Sun, Xiaolei; Zhao, Buchang; Zhao, Chao; Zou, Yunzeng; Hu, Kai; Ding, Xiaoqiang; Sun, Aijun; Ge, Junbo.
Afiliación
  • Wang Y; Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yan X; Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Mi S; Department of Cardiology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Li Z; Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wang Y; SIBS (Institute of Health Sciences)-Changzheng Hospital Joint Center for Translational Medicine, Institute of Health Sciences, Shanghai Changzheng Hospital, Institutes for Translational Medicine (CAS-SMMU), Shanghai, China.
  • Zhu H; Key Laboratory of Stem Cell Biology, Institute of Health Sciences, SIBS, Chinese Academy of Sciences/Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Sun X; SIBS (Institute of Health Sciences)-Changzheng Hospital Joint Center for Translational Medicine, Institute of Health Sciences, Shanghai Changzheng Hospital, Institutes for Translational Medicine (CAS-SMMU), Shanghai, China.
  • Zhao B; Key Laboratory of Stem Cell Biology, Institute of Health Sciences, SIBS, Chinese Academy of Sciences/Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Zhao C; Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zou Y; Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Hu K; Shandong Buchang Pharmaceutical Co., Ltd, Shandong, China.
  • Ding X; Shandong Buchang Pharmaceutical Co., Ltd, Shandong, China.
  • Sun A; Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ge J; Institute of Biomedical Science, Fudan University, Shanghai, China.
J Cell Mol Med ; 21(1): 4-12, 2017 01.
Article en En | MEDLINE | ID: mdl-27785882
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Medicinas Complementárias: Homeopatia Asunto principal: Medicamentos Herbarios Chinos / Daño por Reperfusión Miocárdica / Daño por Reperfusión / Inflamasomas / Proteína con Dominio Pirina 3 de la Familia NLR Tipo de estudio: Prognostic_studies Idioma: En Revista: J Cell Mol Med Año: 2017 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Medicinas Complementárias: Homeopatia Asunto principal: Medicamentos Herbarios Chinos / Daño por Reperfusión Miocárdica / Daño por Reperfusión / Inflamasomas / Proteína con Dominio Pirina 3 de la Familia NLR Tipo de estudio: Prognostic_studies Idioma: En Revista: J Cell Mol Med Año: 2017 Tipo del documento: Article País de afiliación: China